Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
355 GBX | -0.56% | -1.93% | +0.71% |
05-22 | MaxCyte inks deal with Legend Biotech for tech supply | AN |
05-22 | MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.71% | 477M | |
+7.31% | 217B | |
+12.99% | 194B | |
+19.71% | 143B | |
+30.60% | 111B | |
+1.71% | 64.3B | |
+15.23% | 52.94B | |
+2.06% | 49.53B | |
-5.49% | 38.31B | |
-0.22% | 35.22B |
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- Insider Sell: Maxcyte